Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

Drug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral eye infection in AIDS patients.

Valganciclovir tablets are used in the treatment cytomegalovirus infection (serious viral eye infection of the retina) in AIDS patients and in prevention of cytomegalovirus (CMV) disease after organ transplant.

The approved products is a generic therapeutic equivalent version of Roche’s Valcyte.

Cipla has received approval for the product in the strength of 450 mg from the United States Food and Drug Administration (USFDA), the company said in a BSE filing.

Quoting IQVIA (IMS Health) data, Cipla said Valcyte and its generic equivalents had US sales of around USD 79 million for the 12-month period ending September 2018.

Shares of Cipla were trading 1.09 per cent higher at Rs 532.95 apiece on BSE.

  • Related Posts

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    Women’s Deaths in Kota Hospital: The continuous deaths of women in Kota’s government hospitals have raised serious questions regarding health arrangements. After the Medical College Hospital, an outcry has now…

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    New Delhi: The Indian Council of Medical Research (ICMR) participated in the national programme ‘विज्ञान–Tech’, organised on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology (NII), New…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

    Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

    Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

    Patient dies after oxygen supply stops in ambulance

    Patient dies after oxygen supply stops in ambulance

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    IndiaAI, ICMR sign MoU to advance AI in healthcare

    Illegal drug manufacturing racket busted in Baddi area

    Illegal drug manufacturing racket busted in Baddi area